Trials / Conditions / Hydroxymethylglutaryl-CoA Reductase Inhibitors

Hydroxymethylglutaryl-CoA Reductase Inhibitors

11 registered clinical trials studyying Hydroxymethylglutaryl-CoA Reductase Inhibitors.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. NCT06423365	University of Utah	N/A
Active Not Recruiting	Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients NCT05537948	National Medical Research Center for Therapy and Preventive Medicine	Phase 4
Unknown	Assessment of Change in Atherosclerotic Plaque by Serial CCTA NCT03414840	Yonsei University	—
Completed	Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome NCT05306990	Helwan University	N/A
Completed	The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients NCT03785509	Samsung Medical Center	—
Completed	The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion NCT03018444	University Hospital, Gentofte, Copenhagen	N/A
Unknown	Single Dose of Atorvastatin and Circulating Endothelial Microparticles NCT02023892	Sun Yat-sen University	Phase 4
Completed	Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions NCT01241903	Susan Smyth	Phase 1
Withdrawn	Muscle Characteristics Associated With Statin Therapy NCT00990834	Scripps Health	N/A
Completed	The Effect of Statin Medications on Muscle Performance (The STOMP Study) NCT00609063	Hartford Hospital	N/A
Completed	Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment NCT01200056	Prof. Stephen Lee	Phase 4